The Australian Government has welcomed today\u2019s decision by Australia\u2019s medicines regulator, the Therapeutic Goods Administration (TGA), to provisionally approve the use of the Moderna (Spikevax) COVID-19 vaccine for adolescents aged 12 to 17 years.
\nThe approval by the TGA to allow the 12 to 17-year-old age group to be vaccinated with the Moderna COVID-19 vaccine follows the approval last month of its use in adults aged 18 years and older.
\nAustralia has an advance purchase agreement with Moderna to secure 25 million doses of the vaccine \u2013 10 million this year and 15 million of booster vaccines in 2022, with the first doses arriving later this month.
\nThe Government will now await the advice of the independent Australian Technical Advisory Group on Immunisation (ATAGI) on how the approval of the Moderna vaccine for 12 to 17-year-olds should be incorporated into Australia\u2019s vaccine rollout program. This advice is expected in the coming week.
\nThe TGA\u2019s approval of the Moderna vaccine for 12 to 17-year-olds was based on a detailed evaluation of available data to support its safety and efficacy \u2013 and is an important step in the Government\u2019s program to vaccinate children.
\nIt follows the Government accepting ATAGI\u2019s advice that the Pfizer vaccine be administered in adolescents aged 12 to 15 years. Bookings for this age group open on 13 September.
\nSignificant preparatory work has been undertaken by Operation COVID Shield on how the rollout will be expanded by including the Moderna vaccine and the first doses of the Moderna vaccine will be available through community pharmacies and workplace vaccination clinics.
\nThrough increased supply and additional vaccination sites coming on board, we are setting vaccination records on an almost daily basis. Almost 2 million vaccines were administered last week and more than 20 million have now been administered across the country.
\nThe Government is absolutely committed to vaccinating children as part of the rollout program \u2013 and it is expected everyone aged 12 to 18 years of age will have access to a vaccine during 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"
The Australian Government has welcomed today\u2019s decision by Australia\u2019s medicines regulator, the Therapeutic Goods Administration (TGA), to provisionally approve the use of the Moderna (Spikevax) COVID-19 vaccine for adolescents aged 12 to 17 years. The approval by the TGA to allow the 12 to 17-year-old age group to be vaccinated with the Moderna COVID-19 vaccine … Continue reading “TGA approves Moderna vaccine for 12 to 17-year-olds”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-12815","post","type-post","status-publish","format-standard","hentry","category-aussie"],"_links":{"self":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts\/12815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=12815"}],"version-history":[{"count":0,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts\/12815\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=12815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=12815"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=12815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}